The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robust T Cell Immunity in Convalescent Individuals with Asymptomatic or Mild COVID-19
Sekine, T., Perez-Potti, A., Rivera-Ballesteros, O., Strålin, K., Gorin, J.-B., Olsson, A., Llewellyn-Lacey, S., Kamal, H., Bogdanovic, G., Muschiol, S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.08.017 · Cited by 1,788
Mathew, D., Giles, J. R., Baxter, A. E., Oldridge, D. A., Greenplate, A. R., Wu, J. E., Alanio, C., Kuri-Cervantes, L., Pampena, M. B., D’Andrea, K., et al. (2020) · Science · doi:10.1126/science.abc8511 · Cited by 1,509
Engineering hybrid exosomes by membrane fusion with liposomes
Sato, Y. T., Umezaki, K., Sawada, S., Mukai, S.-A., Sasaki, Y., Harada, N., Shiku, H., & Akiyoshi, K. (2016) · Scientific Reports · doi:10.1038/srep21933 · Cited by 744
Escape of SARS-CoV-2 501Y.V2 from neutralization by convalescent plasma
Network for Genomic Surveillance in South Africa, Cele, S., COMMIT-KZN Team, Gazy, I., Jackson, L., Hwa, S.-H., Tegally, H., Lustig, G., Giandhari, J., Pillay, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03471-w · Cited by 651
Tang, F., Quan, Y., Xin, Z.-T., Wrammert, J., Ma, M.-J., Lv, H., Wang, T.-B., Yang, H., Richardus, J. H., Liu, W., et al. (2011) · The Journal of Immunology · doi:10.4049/jimmunol.0903490 · Cited by 496
Channappanavar, R., Fett, C., Zhao, J., Meyerholz, D. K., & Perlman, S. (2014) · Journal of Virology · doi:10.1128/jvi.01505-14 · Cited by 411 · cited 1×
“In contrast, the life-span of memory B cells is significantly shorter in the host.(34,36) Therefore, T cell epitope-based vaccines are expected to provide long-lasting preventive and therapeutic effects against SARS-CoV-2 infection by inducing specific T cell responses.”
BackgroundLessons for COVID-19 immunity from other coronavirus infections
Sariol, A., & Perlman, S. (2020) · Immunity · doi:10.1016/j.immuni.2020.07.005 · Cited by 317
Research works printed but not linked: 32
- Chen Y, Yin S, Tong X, et al. Dynamic SARS-CoV-2-specific B-cell and T-cell responses following immunization with an inactivated COVID-19 vaccine. Clin Microbiol Infect. 2021;28(3):410–418. doi: 10.1016/j.cmi.2021.10.006 · DOI
- Anand SP, Prévost J, Nayrac M, et al. Longitudinal analysis of humoral immunity against SARS-CoV-2 Spike in convalescent individuals up to 8 months post-symptom onset. Cell Rep Med. 2021;2(6):100290. doi: 10.1016/j.xcrm.2021.100290 · DOI
- Koerber N, Priller A, Yazici S, et al. Dynamics of spike-and nucleocapsid specific immunity during long-term follow-up and vaccination of SARS-CoV-2 convalescents. Nat Commun. 2022;13(1):153. doi: 10.1038/s41467-021-27649-y · DOI
- Liu C, Ginn HM, Dejnirattisai W, et al. Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell. 2021;184(16):4220–4236 e4213. doi: 10.1016/j.cell.2021.0 · DOI
- Murano K, Guo Y, Siomi H. The emergence of SARS-CoV-2 variants threatens to decrease the efficacy of neutralizing antibodies and vaccines. Biochem Soc Trans. 2021;49(6):2879–2890. doi: 10.1042/BST20210859 · DOI
- Ni L, Ye F, Cheng ML, et al. Detection of SARS-CoV-2-specific humoral and cellular immunity in COVID-19 convalescent individuals. Immunity. 2020;52(6):971–977 e973. doi: 10.1016/j.immuni.2020.04.023 · DOI
- Melenotte C, Silvin A, Goubet AG, et al. Immune responses during COVID-19 infection. Oncoimmunology. 2020;9(1):1807836. doi: 10.1080/2162402X.2020.1807836 · DOI
- Tay MZ, Poh CM, Renia L, MacAry PA, Ng LFP. The trinity of COVID-19: immunity, inflammation and intervention. Nat Rev Immunol. 2020;20(6):363–374. doi: 10.1038/s41577-020-0311-8 · DOI · Paper page
- Goletti, 2021, Clin Microbiol Infect, 27, 1784, 10.1016/j.cmi.2021.07.005 · DOI
- Sauer, 2020, Front Immunol, 11, 581807, 10.3389/fimmu.2020.581807 · DOI
- Kalluri, 2020, Science, 367, 10.1126/science.aau6977 · DOI · Paper page
- Lv, 2020, Cell Death Differ, 27, 210, 10.1038/s41418-019-0349-y · DOI
- Tang, 2019, Theranostics, 9, 4740, 10.7150/thno.33520 · DOI
- Chaput, 2004, J Immunol, 172, 2137, 10.4049/jimmunol.172.4.2137 · DOI
- Mehanny, 2021, Adv Drug Deliv Rev, 164, 10.1016/j.addr.2021.03.016 · DOI
- Zhang, 2020, Biochem Biophys Res Commun, 526, 341, 10.1016/j.bbrc.2020.03.092 · DOI
- Kuate, 2007, Virology, 362, 26, 10.1016/j.virol.2006.12.011 · DOI
- Kooijmans, 2016, J Control Release, 224, 77, 10.1016/j.jconrel.2016.01.009 · DOI
- Chen, 2013, Am J Nephrol, 37, 191, 10.1159/000347031 · DOI
- Jin, 2021, Cell Mol Immunol, 18, 2588, 10.1038/s41423-021-00784-8 · DOI
- Tang, 2020, Theranostics, 10, 8111, 10.7150/thno.47865 · DOI
- Tang, 2021, J Am Soc Nephrol, 32, 2467, 10.1681/ASN.2020111561 · DOI
- Gangadaran, 2018, Front Pharmacol, 9, 817, 10.3389/fphar.2018.00817 · DOI
- Sutaria, 2017, Pharm Res, 34, 1053, 10.1007/s11095-017-2123-5 · DOI · Paper page
- Tian, 2018, Biomaterials, 150, 137, 10.1016/j.biomaterials.2017.10.012 · DOI · Paper page
- Jia, 2018, Biomaterials, 178, 302, 10.1016/j.biomaterials.2018.06.029 · DOI · Paper page
- Piffoux, 2018, Acs Nano, 12, 6830, 10.1021/acsnano.8b02053 · DOI
- Wan, 2018, Cancer Res, 78, 798, 10.1158/0008-5472.CAN-17-2880 · DOI
- Rodriguez, 2020, Cell Rep Med, 1, 100078, 10.1016/j.xcrm.2020.100078 · DOI
- Rammensee, 2021, Vaccines, 9, 428, 10.3390/vaccines9050428 · DOI
- Zhuang, 2021, J Exp Med, 218, e20202187, 10.1084/jem.20202187 · DOI
- Takagi, 2021, J Virol, 95, e01837, 10.1128/JVI.01837-20 · DOI
Metadata
- Authors
- Shen, A.-R., Jin, X.-X., Tang, T.-T., Ding, Y., Liu, X.-T., Zhong, X., Wu, Y.-D., Han, X.-L., Zhao, G.-Y., Shen, C.-L., Lv, L.-L., & Liu, B.-C.
- Venue
- International Journal of Nanomedicine
- Publisher
- Informa UK Limited
- Published
- 2022-07
- Volume
- Volume 17
- Pages
- 3325-3341
- ISSN
- 1178-2013
- Cited by
- 19
- References
- 7
- Language
- en
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice. https://app.cochat.ai/papers/10.2147/ijn.s367494
- The paper
- Shen, A.-R., Jin, X.-X., Tang, T.-T., Ding, Y., Liu, X.-T., Zhong, X., Wu, Y.-D., Han, X.-L., Zhao, G.-Y., Shen, C.-L., Lv, L.-L., & Liu, B.-C. (2022). Exosomal Vaccine Loading T Cell Epitope Peptides of SARS-CoV-2 Induces Robust CD8+ T Cell Response in HLA-A Transgenic Mice. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s367494
